Detalles de la búsqueda
1.
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed.
Antimicrob Agents Chemother
; 66(3): e0199121, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35007139
2.
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant Enterobacterales Are Critical Priority Pathogens, Too!"
Antimicrob Agents Chemother
; 66(4): e0022322, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35323014
3.
Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.
J Antimicrob Chemother
; 72(10): 2796-2803, 2017 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29091195
4.
Identification of Novel VEB ß-Lactamase Enzymes and Their Impact on Avibactam Inhibition.
Antimicrob Agents Chemother
; 60(5): 3183-6, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26926646
5.
Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914).
Antimicrob Agents Chemother
; 60(1): 621-3, 2016 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26482313
6.
In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.
Antimicrob Agents Chemother
; 60(1): 343-7, 2016 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26503659
7.
Identification of non-PBP2a resistance mechanisms in Staphylococcus aureus after serial passage with ceftaroline: involvement of other PBPs.
J Antimicrob Chemother
; 71(11): 3050-3057, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27494915
8.
Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline.
J Antimicrob Chemother
; 71(1): 34-40, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26483514
9.
Structural and sequence analysis of class A ß-lactamases with respect to avibactam inhibition: impact of Ω-loop variations.
J Antimicrob Chemother
; 71(10): 2848-55, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27402011
10.
Insights into the mechanism of inhibition of novel bacterial topoisomerase inhibitors from characterization of resistant mutants of Staphylococcus aureus.
Antimicrob Agents Chemother
; 59(9): 5278-87, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26077256
11.
The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility.
Antimicrob Agents Chemother
; 59(1): 427-36, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25367914
12.
In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolates Collected in 2012 from Latin American Countries as Part of the AWARE Surveillance Program.
Antimicrob Agents Chemother
; 59(12): 7873-7, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26416860
13.
In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria.
Antimicrob Agents Chemother
; 59(1): 467-74, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25385112
14.
Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae.
Antimicrob Agents Chemother
; 59(3): 1478-86, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25534723
15.
Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3.
J Antimicrob Chemother
; 70(5): 1420-8, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25634992
16.
Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline.
J Antimicrob Chemother
; 70(9): 2488-98, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26045529
17.
Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC.
J Antimicrob Chemother
; 70(6): 1650-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25645206
18.
High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea.
Antimicrob Agents Chemother
; 58(9): 5585-8, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24982070
19.
Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C ß-lactamase enzyme.
J Antimicrob Chemother
; 69(11): 2942-6, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24986496
20.
Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective.
J Antimicrob Chemother
; 69(8): 2065-75, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24777906